🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will treat participants with newly diagnosed, low, intermediate ...
Status
Active Not Recruiting
Location
University of Florida Proton Therapy Institute
Start Date
2013-12-04
Trial ID
NCT01871766
Primary and secondary brain tumors, the leading cause of death from cancer ...
Status
Recruiting
Location
Service de Neurochirurgie - Hôpital de la Pitié Salpêtrière
Start Date
2024-03-26
Trial ID
NCT06314607
Treatments Being Tested
The pathophysiology of neurological toxicities secondary to immune checkpoi...
Status
Recruiting
Location
Hôpital Bicêtre AP-HP
Start Date
2026-04-09
Trial ID
NCT07456358
Treatments Being Tested
Single center, non-randomized, Phase 0 study. Sacituzumab Govitecan given p...
Status
Completed
Location
Mays Cancer Center, UT Health San Antonio
Start Date
2019-07-17
Trial ID
NCT03995706
Treatments Being Tested
The most clinically meaningful way to discover new targets of T cells in au...
Status
Recruiting
Location
Knowledge Research Center
Start Date
2023-01-03
Trial ID
NCT06587828
Treatments Being Tested
Progranulin (GRN or PGRN) mutations are among the most common genetic cause...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-01
Trial ID
NCT06711510
Multiple sclerosis (MS) has long been considered a disease mediated primari...
Status
Completed
Location
CHU Rennes
Start Date
2021-03-23
Trial ID
NCT04697407
Treatments Being Tested
Neurodegenerative diseases, including frontotemporal lobar degeneration (FT...
Status
Enrolling By Invitation
Location
IRCCS San Raffaele
Start Date
2017-06-01
Trial ID
NCT07567664
In order to better determine which therapy is best for patiënts which prese...
Status
Recruiting
Location
University Hospital Antwerp
Start Date
2024-03-13
Trial ID
NCT06928649
Treatments Being Tested
Embryologic phenomenons that lead to dysraphisms are known, but pathophysio...
Status
Completed
Location
chu de Lille
Start Date
2024-05-16
Trial ID
NCT07611058
Treatments Being Tested